Search
01/08/2022
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab
Chaparro, M, Baston-Rey, I, Salgado, EF, Garcia, JG, Ramos, L, Palomares, MTDL, Arguelles-Arias, F, Flores, EI, Cabello, M, Iturria, SR, Ortiz, AN, Charro, M, Ginard, D, Sadornil, CD, Ochoa, OM, Busquets, D, Iyo, E, Casbas, AG, de la Piscina, PR, Bosca-Watts, MM, Arroyo, M, Garcia, MJ, Hinojosa, E, Gordillo, J, Montiel, PM, Jimenez, BV, Ivorra, CQ, Moron, JMV, Huguet, JM, Gonzalez-Lama, Y, Santos, AIM, Amo, VM, Arranz, MDM, Bermejo, F, Cadilla, JM, de Celix, CR, Salazar, PF, San Roman, AL, Jimenez, N, Garcia-Lopez, S, Figuerola, A, Jimenez, I, Cerezo, FJM, Taxonera, C, Varela, P, de Francisco, R, Monfort, D, Arriero, GM, Hernandez-Camba, A, Alonso, FJG, Van Domselaar, M, Pajares-Villarroya, R, Nunez, A, Moranta, FR, Marin-Jimenez, I, Alonso, VR, Rodriguez, MDM, Camo-Monterde, P, Tercero, IG, Navarro-Llavat, M, Garcia, LA, Cruz, DH, Kloss, S, Passey, A, Novella, C, Vispo, E, Barreiro-de Acosta, M, Gisbert, JP. Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab. Journal of Clinical Medicine. 2022; 11(15)DOI:10.3390/jcm11154518. PMID:35956133. IF:3.900(Q2/4D).
01/08/2022
Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study
Babich, T, Naucler, P, Valik, JK, Giske, CG, Benito, N, Cardona, R, Rivera, A, Pulcini, C, Fattah, MA, Haquin, J, Macgowan, A, Grier, S, Chazan, B, Yanovskay, A, Ben Ami, R, Landes, M, Nesher, L, Zaidman-Shimshovitz, A, McCarthy, K, Paterson, DL, Tacconelli, E, Buhl, M, Mauer, S, Rodriguez-Bano, J, de Cueto, M, Oliver, A, de Gopegui, ER, Cano, A, Machuca, I, Gozalo-Marguello, M, Martinez-Martinez, L, Gonzalez-Barbera, EM, Alfaro, IG, Salavert, M, Beovic, B, Saje, A, Mueller-Premru, M, Pagani, L, Vitrat, V, Kofteridis, D, Zacharioudaki, M, Maraki, S, Weissman, Y, Paul, M, Dickstein, Y, Leibovici, L, Yahav, D. Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study. Infectious Diseases and Therapy. 2022; 11(4)DOI:10.1007/s40121-022-00657-1. PMID:35612693. IF:5.400(Q2/3D).
01/08/2022
Decreased mortality among patients with catheter- related bloodstream infections at Catalan hospitals (2010-2019)
Badia-Cebada, L, Penafiel, J, Lopez-Contreras, J, Pomar, V, Martinez, JA, Santana, G, Cuquet, J, Montero, MM, Hidalgo-Lopez, C, Andres, M, Gimenez, M, Quesada, MD, Vaque, M, Iftimie, S, Gudiol, C, Perez, R, Coloma, A, Marron, A, Barrufet, P, Marimon, M, Lerida, A, Claros, M, Ramirez-Hidalgo, MF, Pardo, GG, Martinez, MJ, Chamarro, EL, Jimenez-Martinez, E, Hornero, A, Limon, E, Lopez, M, Calbo, E, Pujol, M, Gasch, O. Decreased mortality among patients with catheter- related bloodstream infections at Catalan hospitals (2010-2019). JOURNAL OF HOSPITAL INFECTION. 2022; 126DOI:10.1016/j.jhin.2022.05.009. PMID:35594988. IF:6.900(Q1/2D).
01/08/2022
Autoimmunity in the Study of Interstitial Lung Disease: Are Serological Test Enough?
Castellví I., Vidal S., Valenzuela C.. Autoimmunity in the Study of Interstitial Lung Disease: Are Serological Test Enough?. ARCHIVOS DE BRONCONEUMOLOGIA. 2022; 58(8)DOI:10.1016/j.arbres.2021.08.016. PMID:35312568. IF:8.000(Q1/2D).